Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Avid Bioservices ( (CDMO) ) has shared an update.
At Avid Bioservices’ 2024 Annual Meeting, stockholders approved significant amendments to the 2018 Omnibus Incentive Plan, adding 3.8 million shares for grants, and the 2010 Employee Stock Purchase Plan, eliminating its automatic termination clause. Additionally, Ernst & Young LLP was ratified as the independent auditor, and all nominated directors were elected. These changes reflect strategic financial decisions aimed at enhancing shareholder value and improving the company’s compensation structure.
Find detailed analytics on CDMO stock on TipRanks’ Stock Analysis page.
